Overview
Lab technology firm's fiscal Q1 revenue grows 7% yr/yr, slightly missing analyst expectations
Adjusted EPS for fiscal Q1 missed analyst expectations despite 4% growth yr/yr
Outlook
Agilent raises FY26 revenue outlook to $7.3 bln-$7.5 bln
Company expects FY26 non-GAAP EPS between $5.90 and $6.04
Agilent forecasts Q2 2026 revenue of $1.79 bln-$1.82 bln
Result Drivers
INSTRUMENT REPLACEMENT CYCLE - Continued momentum in instrument-replacement cycle contributed to revenue growth
ENTERPRISE SERVICES ENGAGEMENT - Strong engagement in Enterprise Services supported revenue growth
Company press release: ID:nBw1rXKV7a
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Slight Miss*
$1.80 bln
$1.81 bln (15 Analysts)
Q1 Adjusted EPS
Miss
$1.36
$1.37 (16 Analysts)
Q1 EPS
$1.07
Q1 Adjusted Net Income
Miss
$386 mln
$390.36 mln (12 Analysts)
Q1 Net Income
$305 mln
Q1 Pretax Profit
$364 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Agilent Technologies Inc is $170.00, about 36.7% above its February 24 closing price of $124.40
The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 24 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
